Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2017, Article ID 8597629, 6 pages
https://doi.org/10.1155/2017/8597629
Research Article

Pattern Visual Evoked Potential Changes in Diabetic Patients without Retinopathy

1Department of Ophthalmology, Dr. Nafiz Korez Sincan State Hospital, Ankara, Turkey
2Department of Ophthalmology, Ankara Training and Research Hospital, Ankara, Turkey
3Department of Family Medicine, Yildirim Beyazit University Faculty of Medicine, Ankara, Turkey

Correspondence should be addressed to Ozgur Balta; moc.liamtoh@atlabrugzord

Received 7 December 2016; Revised 9 February 2017; Accepted 20 February 2017; Published 14 March 2017

Academic Editor: Lisa Toto

Copyright © 2017 Ozgur Balta et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. WHO, Global Report on Diabetes, World Health Organization, Geneva, 2016. View at Publisher · View at Google Scholar
  2. I. M. Stratton, E. M. Kohner, S. J. Aldington et al., “UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis,” Diabetologia, vol. 44, no. 2, pp. 156–163, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. R. R. Bourne, G. A. Stevens, R. A. White et al., “Causes of vision loss worldwide, 1990-2010: a systematic analysis,” The Lancet Global Health, vol. 1, no. 6, pp. e339–e349, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. The Diabetes Control and Complications (DCCT) Research Group, “Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial,” Kidney International, vol. 47, no. 6, pp. 1703–1720, 1995. View at Google Scholar
  5. Diabetes Control and Complications Trial Research Group, “The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial,” Diabetes, vol. 44, no. 8, pp. 968–983, 1995. View at Google Scholar
  6. M. Rodriguez-Fontal, J. B. Kerrison, D. V. Alfaro, and E. P. Jablon, “Metabolic control and diabetic retinopathy,” Current Diabetes Reviews, vol. 5, no. 1, pp. 3–7, 2009. View at Google Scholar
  7. H. A. Kahn and R. F. Bradley, “Prevalence of diabetic retinopathy. Age, sex, and duration of diabetes,” The British Journal of Ophthalmology, vol. 59, no. 7, pp. 345–349, 1975. View at Google Scholar
  8. R. Klein, B. E. Klein, S. E. Moss, M. D. Davis, and D. L. DeMets, “The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years,” Archives of Ophthalmology, vol. 102, no. 4, pp. 520–526, 1984. View at Publisher · View at Google Scholar
  9. P. Walsh, N. Kane, and S. Butler, “The clinical role of evoked potentials,” Journal of Neurology, Neurosurgery, and Psychiatry, vol. 76, Supplement 2, pp. ii16–ii22, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. J. L. Carter, “Visual evoked potentials,” Clinical Neurophysiology, Oxford University Press, New York, 2009. View at Google Scholar
  11. J. V. Odom, M. Bach, C. Barber et al., “Visual evoked potentials standard (2004),” Documenta Ophthalmologica Advances in Ophthalmology, vol. 108, no. 2, pp. 115–123, 2004. View at Google Scholar
  12. J. V. Odom, M. Bach, M. Brigell et al., “ISCEV standard for clinical visual evoked potentials: (2016 update),” Documenta Ophthalmologica Advances in Ophthalmology, vol. 133, no. 1, pp. 1–9, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. American Clinical Neurophysiology Society, “Guideline 5: guidelines for standard electrode position nomenclature,” Journal of Clinical Neurophysiology, vol. 23, no. 2, pp. 107–110, 2006, https://www.acns.org/ View at Google Scholar
  14. J. W. Yau, S. L. Rogers, R. Kawasaki et al., “Global prevalence and major risk factors of diabetic retinopathy,” Diabetes Care, vol. 35, no. 3, pp. 556–564, 2012. View at Google Scholar
  15. M. Algan, O. Ziegler, P. Gehin et al., “Visual evoked potentials in diabetic patients,” Diabetes Care, vol. 12, no. 3, pp. 227–229, 1989. View at Google Scholar
  16. E. Mariani, G. Moreo, and G. B. Colucci, “Study of visual evoked potentials in diabetics without retinopathy: correlations with clinical findings and polyneuropathy,” Acta Neurologica Scandinavica, vol. 81, no. 4, pp. 337–340, 1990. View at Google Scholar
  17. A. Collier, W. Reid, A. McInnes, R. E. Cull, D. J. Ewing, and B. F. Clarke, “Somatosensory and visual evoked potentials in insulin-dependent diabetics with mild peripheral neuropathy,” Diabetes Research and Clinical Practice, vol. 5, no. 3, pp. 171–175, 1988. View at Google Scholar
  18. G. Y. Ozawa, M. A. Bearse Jr., and A. J. Adams, “Male-female differences in diabetic retinopathy?” Current Eye Research, vol. 40, no. 2, pp. 234–246, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Y. Ozawa, M. A. Bearse Jr., K. W. Bronson-Castain et al., “Neurodegenerative differences in the retinas of male and female patients with type 2 diabetes,” Investigative Ophthalmology & Visual Science, vol. 53, no. 6, pp. 3040–3046, 2012. View at Publisher · View at Google Scholar
  20. R. Klein, B. E. Klein, S. E. Moss, M. D. Davis, and D. L. DeMets, “The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years,” Archives of Ophthalmology, vol. 102, no. 4, pp. 527–532, 1984. View at Publisher · View at Google Scholar
  21. R. Klein, B. E. Klein, S. E. Moss, and K. J. Cruickshanks, “The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy,” Archives of Ophthalmology, vol. 112, no. 9, pp. 1217–1228, 1994. View at Publisher · View at Google Scholar
  22. P. Namperumalsamy, R. Kim, T. P. Vignesh et al., “Prevalence and risk factors for diabetic retinopathy: a population-based assessment from Theni District, south India,” The British Journal of Ophthalmology, vol. 93, no. 4, pp. 429–434, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Fein and F. F. Brown, “Gender differences in pattern reversal evoked potentials in normal elderly,” Psychophysiology, vol. 24, no. 6, pp. 683–690, 1987. View at Google Scholar
  24. S. Tobimatsu, “Aging and pattern visual evoked potentials,” Optometry and Vision Science, vol. 72, no. 3, pp. 192–197, 1995. View at Google Scholar
  25. P. G. Raman, K. Sodani, and B. George, “A study of visual evoked potential changes in diabetes mellitus,” International Journal of Diabetes in Developing Countries, vol. 17, pp. 69–73, 1997. View at Google Scholar
  26. A. K. Lana, A A.-m. Khalid, K. S. Sarkis, and M. AAAIi, “The study of visual evoked potential in patients with diabetes mellitus,” The Medical Journal of Basrah University, vol. 27, no. 2, pp. 55–65, 2009. View at Google Scholar
  27. S. Gupta, G. Gupta, and V. K. Deshp, “Visual evoked potential changes in patients with diabetes mellitus without retinopathy,” International Journal of Research in Medical Sciences, vol. 3, no. 12, pp. 3591–3598, 2015. View at Publisher · View at Google Scholar
  28. J. Heravian, A. Ehyaei, N. Shoeibi et al., “Pattern visual evoked potentials in patients with type II diabetes mellitus,” Journal of Ophthalmic & Vision Research, vol. 7, no. 3, pp. 225–230, 2012. View at Google Scholar
  29. D. Chopra, M. Gupta, K. C. Manchanda, R. S. Sharma, and R. S. Sidhu, “A study of visual evoked potentials in patients of type-2 diabetes mellitus,” Journal of Clinical and Diagnostic Research, vol. 5, no. 3, pp. 519–522, 2011. View at Google Scholar